Swiss Medical Weekly (Oct 2024)
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data
Abstract
No abstract available.